Flow Cytometry Market Size, Share, Growth Analysis, By Technology(Cell-Based Flow Cytometry, and Bead-Based Flow Cytometry), By Product & Service(Reagents & Consumables (Antibodies, Assays & Kits, Other Reagents & Consumables), Instruments (Cell Analyzers [High-range Cell Analyzers), By Application(Research Applications (Pharmaceutical & Biotechnology [Drug discovery, Stem cell research, In vitro toxicity testing]), Immunology (Cell Sorting), By End User(Academic & Research Institutes, Hospitals & Clinical Testing Laboratories, and Pharmaceutical & Biotechnology Companies), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2031 | Region: Global | Published Date: June, 2024
Pages: 157 |Tables: 130 |Figures: 77

Flow Cytometry Market Insights

Global Flow Cytometry Market size was valued at USD 3.97 Billion in 2022 and is poised to grow from USD 4.25 Billion in 2023 to USD 6.99 Billion by 2031, growing at a CAGR of 7.17% in the forecast period (2024-2031). 

Growth in the industry is attributed to increasing cancer instances, immune system disorders, and infections. High demand for flow cytometry instruments is also due to increased spending on R&D in the biotechnology, life science, and biopharmaceutical industries. Microfluidic flow cytometry for Point-of-Care (POC) testing is an example of the new and enhanced analytical tools that have emerged due to advancement in the technique.

Consequently, the COVID-19 epidemic has led to the growth of flow cytometry. Because of the enhanced accuracy and the number of specimens analyzed per time, the approach offers an opportunity to replace COVID-19 testing because it can avoid the limitations of the current PCR- or antibody-based testing solutions. Therefore, the sector has grown due to the use of flow cytometry approaches in diagnosing COVID-19 and monitoring the disease. The appearance of new products in this area also proves that, despite the pandemic, there are innovations in the field of flow cytometry.

The test uses flow cytometry to reveal important characteristics of a patient’s response to COVID-19 antigens and to make sound management decisions. What is more, it is expected that the adoption of such innovations would promote industry development in the future. The other factor that has influenced the adoption of flow cytometry techniques is the rising incidence of infectious diseases around the world. It is therefore necessary to look for viable substitute methods of immunophenotyping & cell isolation so as to combat these diseases, which annually claim more than 4. 5 million fatalities. This approach can be used to detect pathogenic microorganisms from environmental samples and may serve as a viable immunophenotyping method.

US Flow Cytometry Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 3971.4 million

Largest Segment

Instruments

Fastest Growth

Instruments

Growth Rate

7.17% CAGR

Global Flow Cytometry Market ($ Mn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Flow Cytometry Market Segmental Analysis

The flow cytometry market is segmented based on Technology, Product & Service, Application, End-use, and Region. Based on Technology, the market is segmented into Cell-Based Flow Cytometry, Bead-Based Flow Cytometry. Based on Product & Service, the market is segmented into Reagents & Consumables (Antibodies, Assays & Kits, Other Reagents & Consumables), Instruments (Cell Analyzers [High-range Cell Analyzers, Mid-range Cell Analyzers, Low-range Cell Analyzers], Cell Sorters [High-range Cell Sorters, Mid-range Cell Sorters, Low-range Cell Sorters]), Services, Software, Accessories. Based on Application, the market is segmented into Research Applications (Pharmaceutical & Biotechnology [Drug Discovery, Stem Cell Research, In Vitro Toxicity Testing]), Immunology (Cell Sorting, Apoptosis, Cell Cycle Analysis, Cell Viability, Cell Counting, Other Research Applications), Clinical Applications (Cancer Diagnostics, Hematology, Autoimmune Diseases, Organ Transplantation, Other Clinical Applications), and Industrial Applications. Based on End-user, the market is segmented into Academic & Research Institutes, Hospitals & Clinical Testing Laboratories, and Pharmaceutical & Biotechnology Companies. Based on region, the market is categorized into North America, Europe, Asia-Pacific, South America, and Middle East and Africa.

Analysis by Product & Service

The instrument sector remained the most popular in the fiscal year 2023, holding 35% of the market’s total revenue. 40%, due to improvement in technology. For instance, in June 2023, BD launched an automated device aimed at improving the flow of clinical diagnostics. The improved technological factor that is likely to bring efficiency, accuracy and portability is expected to open up future growth prospects. Additionally, the focus on building instruments with faster turnaround times is expected to have a positive impact on the segment’s growth during the forecast period. 

The software segment is expected to register a significant growth rate from 2024 to 2031. Software plays a crucial role in the processing and data acquisition from cytometers, analysis of information, and delivering statistical advice. In research, the software is used in tissue acquisition as well as data analysis while in clinical applications, it is used to diagnose diseases from patient samples. Such a diverse list of applications creates great expectations regarding the future market trends in the near years. Also, the factor of the launching of new products in the market by some of the leading companies is expected to drive this segment in the future. For example, in February 2023, Agilent released the NovoCyte Flow Cytometer System Software that included enhanced regulatory standards for bio pharma and pharma manufacturing sectors. 

Analysis by Technology

Cell-based flow cytometry commanded the largest revenue share in 2023 and is projected to grow at a 6.41% CAGR from 2024 to 2030. These assays play a crucial role in drug discovery, evaluating cellular physiological traits and analyzing the derived data. Technological advancements, like multi-parameter flow cytometry for rare cell analysis, are expected to boost demand in the coming years. This technology is vital in clinical studies of diverse cells, including tumor cells in peripheral blood, endothelial cells, tumor stem cells, and hematopoietic progenitor cells. It also aids in studying disease mechanisms and identifying therapeutic targets. 

The bead-based assays segment is forecasted to grow at an exponential CAGR from 2024 to 2031. This surge is driven by molecular engineering advancements and monoclonal antibody production, along with benefits such as cost-effectiveness, minimal sample requirements, and swift turnaround times. Utilizing indirect or sandwich immunoassay formats, these assays are tailored to assess antibody levels in biological fluids. Additionally, they have been developed for infectious disease research, with their demand expected to rise significantly during the forecast period.

Global Flow Cytometry Market By Technology (%)

To get detailed analysis on other segments, Request For Free Sample Report

Flow Cytometry Market Regional Insights

North America led the market with a 41.20% revenue share in 2023, driven by a robust healthcare system and pharmaceutical sector in the U.S., generating high demand for flow cytometry in clinical and research applications. Extensive R&D in therapeutics and increased public-private investments in cancer research have further boosted the need for these instruments. For instance, in December 2023, AlleSense was commissioned to advance cancer diagnostics using cutting-edge technologies, with an initial investment of around USD 2.5 million, significantly contributing to market growth.

The Asia-Pacific flow cytometry market is expected to grow significantly from 2024 to 2030 due to the expanding pharmaceutical and biotechnology sectors in emerging economies like China and India. Market growth is driven by the rising prevalence of chronic diseases and increased use of cytometry devices in various applications. Additionally, continuous innovations in cancer and infectious disease research are projected to significantly contribute to regional market growth. Extensive research activities by regional players aiming to develop innovative flow cytometry solutions are also expected to bolster market expansion in Asia-Pacific during the forecast period.

Global Flow Cytometry Market By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Flow Cytometry Market Dynamics

Flow Cytometry Market Driver

Advancements and Demand in Flow Cytometry

  • Flow cytometry is crucial for analyzing cell surface and intracellular molecules, characterizing diverse cell types, and assessing the purity of isolated subpopulations. The market is driven by increased R&D for multicolor assays and advanced reagents. The rising prevalence of chronic and infectious diseases, including COVID-19, has spurred demand, with numerous research institutes and pharmaceutical companies conducting extensive R&D to develop new vaccines and therapies. 

Rising Demand for Personalized Medicine Drives Flow Cytometry Market

  • The increasing focus on personalized medicine, which tailors treatments to individual patients, is a major driver for the flow cytometry market. This technology allows researchers to identify and characterize specific biomarkers, leading to more effective diagnosis and treatment options for a wide range of diseases.

Restraints 

High Costs Impede Flow Cytometry Adoption in Developing Economies

  • Flow cytometry instruments are expensive, and many developing economies cannot afford technologically advanced flow cytometers. These instruments cost between USD 75,000 and USD 100,000 for a four- to six-color and two-laser instrument, posing a significant financial burden on small and medium-sized hospitals and diagnostic laboratories in developing economies. Thermo Fisher Scientific's Attune with a two-laser and six-color instrument costs USD 99,000 in the United States. As a result, the high cost of equipment will likely limit demand for advanced flow cytometers. 

Limited Accessibility in Resource-Poor Settings 

  • Flow cytometry faces a market restraint due to limited accessibility in resource-poor settings. Developing regions often lack the infrastructure and trained personnel required to operate and maintain these sophisticated instruments. This gap restricts the widespread adoption and utilization of flow cytometry, impeding its potential market growth and the ability to deliver advanced diagnostic and research capabilities in underfunded healthcare systems.

Request Free Customization of this report to help us to meet your business objectives.

Flow Cytometry Market Competitive Landscape

The flow cytometry market is considered highly consolidated due to the presence of very few players in the market. These players are holding a huge share of the market and are likely to remain in a similar competitive environment for the next few years. Key market players in the market are Becton, Dickinson and Company, Danaher Corporation Sysmex Corporation, Bio-Rad Laboratories Inc, Luminex Corporation, etc.

Flow Cytometry Market Top Players Company Profiles

  • Becton, Dickinson, and Company (US) 
  • Danaher Corporation (US) 
  • Thermo Fisher Scientific, Inc. (US) 
  • Luminex Corporation (US) 
  • Agilent Technologies, Inc. (US) 
  • Sony Group Corporation (Japan) 
  • Bio-Rad Laboratories, Inc. (US) 
  • Miltenyi Biotec GmbH  (Germany) 
  • Enzo Biochem, Inc. (US) 
  • Sysmex Corporation (Japan) 
  • bioMérieux S.A. (France) 
  • Cytonome/ ST, LLC (US) 
  • Sartorius AG (Germany) 
  • Cytek Biosciences, Inc. (US) 
  • Union Biometrica, Inc. (US) 
  • Fluxion Biosciences, Inc. (US) 
  • GE Healthcare Life Sciences (US) 
  • Nexcelom Bioscience LLC (US) 
  • Apogee Flow Systems Ltd. (UK) 
  • Merck KGaA (Germany) 
  • Beckman Coulter, Inc. (US)

Flow Cytometry Market Recent Developments

  • In May 2024, new spectrally optimized cytometer known as the NovoCyte Opteon Spectral Flow Cytometer which can be provided as either three- or five-laser designs with up to 73 high-performance detectors were unveiled by Agilent Technologies Inc. 

  • The CytoFLEX nano Flow Cytometer was introduced in March, 2024 by Beckman Coulter: The instrument features the capability of simultaneous multiparameter analysis with six fluorescent detection channels and five SSC. 

  • The FP7000 spectral cell sorter that was developed by Sony Corporation in October 2023 showed enhanced sorting capability that can reach speeds of more than 44 colors. It carries out unique sequences of operations, which include optics based on spectral technology, electronics, and fluidics.

Flow Cytometry Key Market Trends

  • Flow cytometry is considered as an excellent tool for characterizing, identifying, and isolating stem cells for research and potential clinical applications. Recent advances in flow cytometric hardware, reagents, and software have enabled stem cell biologists to more fully identify and isolate rare cells. With such widespread use of flow cytometry for disease diagnosis and early detection, adoption in stem cell research is propelling the growth of the flow cytometry market. 
  • An increase in government funding for clinical studies related to in vitro molecular diagnostics is expected to drive the market, as it plays an important role in the development of new products. Increased investment in well-known biotech and biopharma firms has resulted in significant market growth. 
  • Most end-users, such as clinical laboratories, large research facilities, and pharmaceutical companies, require a large number of flow cytometry instruments in order to conduct multiple research studies at the same time. As a result, the capital costs associated with the acquisition and maintenance of these devices soar. Due to limited budgets, such instruments are difficult to obtain for academic and research laboratories.

Flow Cytometry Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research. 

As per the current report of our future analysis, there will be a significant growth in the flow cytometry market in the future due to the increase in development and huge application in various fields of research and diagnosis. Furthermore, integration of flow cytometry technology in new research areas like cytogenomics, proteomics, and sea mammal cell biology would expand the growth of the industry. In addition, increasing disease prevalence rates, for instance, cancer and HIV, are anticipated to foster the use of the flow cytometry technology for diagnosis across diagnostic research areas.

Report Metric Details
Market size value in 2022 USD 3.97 Billion
Market size value in 2031 USD 6.99 Billion
Growth Rate 7.17%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Technology
    • Cell-Based Flow Cytometry, and Bead-Based Flow Cytometry
  • Product & Service
    • Reagents & Consumables (Antibodies, Assays & Kits, Other Reagents & Consumables), Instruments (Cell Analyzers [High-range Cell Analyzers, Mid-range Cell Analyzers, Low-range Cell Analyzers], Cell Sorters [High-range Cell Sorters, Mid-range Cell Sorters, Low-range Cell Sorters]), Services, Software, And Accessories
  • Application
    • Research Applications (Pharmaceutical & Biotechnology [Drug discovery, Stem cell research, In vitro toxicity testing]), Immunology (Cell Sorting, Apoptosis, Cell Cycle Analysis, Cell Viability, Cell Counting, Other Research Applications), Clinical Applications (Cancer Diagnostics, Hematology, Autoimmune Diseases, Organ transplantation, Other Clinical Applications), and Industrial Applications
  • End User
    • Academic & Research Institutes, Hospitals & Clinical Testing Laboratories, and Pharmaceutical & Biotechnology Companies
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Becton, Dickinson, and Company (US) 
  • Danaher Corporation (US) 
  • Thermo Fisher Scientific, Inc. (US) 
  • Luminex Corporation (US) 
  • Agilent Technologies, Inc. (US) 
  • Sony Group Corporation (Japan) 
  • Bio-Rad Laboratories, Inc. (US) 
  • Miltenyi Biotec GmbH  (Germany) 
  • Enzo Biochem, Inc. (US) 
  • Sysmex Corporation (Japan) 
  • bioMérieux S.A. (France) 
  • Cytonome/ ST, LLC (US) 
  • Sartorius AG (Germany) 
  • Cytek Biosciences, Inc. (US) 
  • Union Biometrica, Inc. (US) 
  • Fluxion Biosciences, Inc. (US) 
  • GE Healthcare Life Sciences (US) 
  • Nexcelom Bioscience LLC (US) 
  • Apogee Flow Systems Ltd. (UK) 
  • Merck KGaA (Germany) 
  • Beckman Coulter, Inc. (US)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Flow Cytometry Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Flow Cytometry Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Flow Cytometry Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Flow Cytometry Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Flow Cytometry Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Flow Cytometry Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Flow Cytometry Market size was valued at USD 3.97 Billion in 2022 and is poised to grow from USD 4.25 Billion in 2023 to USD 6.99 Billion by 2031, growing at a CAGR of 7.17% in the forecast period (2024-2031). 

The flow cytometry market is considered highly consolidated due to the presence of very few players in the market. These players are holding a huge share of the market and are likely to remain in a similar competitive environment for the next few years. Key market players in the market are Becton, Dickinson and Company, Danaher Corporation Sysmex Corporation, Bio-Rad Laboratories Inc, Luminex Corporation, etc. 'Becton, Dickinson, and Company (US) ', 'Danaher Corporation (US) ', 'Thermo Fisher Scientific, Inc. (US) ', 'Luminex Corporation (US) ', 'Agilent Technologies, Inc. (US) ', 'Sony Group Corporation (Japan) ', 'Bio-Rad Laboratories, Inc. (US) ', 'Miltenyi Biotec GmbH  (Germany) ', 'Enzo Biochem, Inc. (US) ', 'Sysmex Corporation (Japan) ', 'bioMérieux S.A. (France) ', 'Cytonome/ ST, LLC (US) ', 'Sartorius AG (Germany) ', 'Cytek Biosciences, Inc. (US) ', 'Union Biometrica, Inc. (US) ', 'Fluxion Biosciences, Inc. (US) ', 'GE Healthcare Life Sciences (US) ', 'Nexcelom Bioscience LLC (US) ', 'Apogee Flow Systems Ltd. (UK) ', 'Merck KGaA (Germany) ', 'Beckman Coulter, Inc. (US)'

Flow cytometry faces a market restraint due to limited accessibility in resource-poor settings. Developing regions often lack the infrastructure and trained personnel required to operate and maintain these sophisticated instruments. This gap restricts the widespread adoption and utilization of flow cytometry, impeding its potential market growth and the ability to deliver advanced diagnostic and research capabilities in underfunded healthcare systems.

Flow cytometry is considered as an excellent tool for characterizing, identifying, and isolating stem cells for research and potential clinical applications. Recent advances in flow cytometric hardware, reagents, and software have enabled stem cell biologists to more fully identify and isolate rare cells. With such widespread use of flow cytometry for disease diagnosis and early detection, adoption in stem cell research is propelling the growth of the flow cytometry market. 

North America led the market with a 41.20% revenue share in 2023, driven by a robust healthcare system and pharmaceutical sector in the U.S., generating high demand for flow cytometry in clinical and research applications. Extensive R&D in therapeutics and increased public-private investments in cancer research have further boosted the need for these instruments. For instance, in December 2023, AlleSense was commissioned to advance cancer diagnostics using cutting-edge technologies, with an initial investment of around USD 2.5 million, significantly contributing to market growth.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Report ID: SQMIG35H2031

$5,300
BUY NOW GET FREE SAMPLE